EMS

Capivari, Brazil Founded: 1964 • Age: 62 yrs
RD based manufacturer of drugs for multiple therapeutic areas

About EMS

EMS is a Healthcare company based in Capivari (Brazil) founded in 1964. RD based manufacturer of drugs for multiple therapeutic areas. EMS has completed 5 acquisitions, including Dermacyd, Galenika and Lactacyd. Its website ems.com.br draws about 103 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Maine Potato Growers, Inc.

Company details

EMS, established in 1964, excels in providing healthcare solutions, traditional pharmaceuticals, generics, and diversified. RD based manufacturer of drugs for multiple therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Capivari, Brazil
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website ems.com.br
  • Legal Name Maine Potato Growers, Inc
Key Metrics

Funding Insights of EMS

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $15M
  • First Round $15M

    (Aug 2014)

  • Investors Count 1

All 1 funding rounds of EMS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2014$15MDebt – Conventional––
Valuation history

1 investors in total: 1 institutional.

Investors in EMS

EMS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Crystal Financial.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Debt financing is offered to US tech and offline companies.
1993crystalfinco.comBoston, United States
Premium access

Investor details for EMS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by EMS

EMS has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Dermacyd, Galenika and Lactacyd.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Branded generic pharmaceuticals are manufactured and marketed across therapeutic categories.
medley.com.brCampinas, Brazil2011Mar 2026β€’β€’β€’β€’
Customized nutritional supplements are offered via an online platform.
vitaminese.com.brSao Paulo, Brazil2021Jul 2024β€’β€’β€’β€’
Personal hygiene products are offered by Lactacyd brand in Europe.
lactacyd.euFrance1950Jun 2023β€’β€’β€’β€’
Brand of soaps
dermacyd.com.brBrazil2020May 2023β€’β€’β€’β€’
Prescribed drugs, OTC products, medical devices, and pharmaceuticals are manufactured.
galenika.rsBelgrade, Serbia1991Jun 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for EMS

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of EMS

7 dated milestones of EMS across 62 years, from founding to its latest funding, stage changes and deals.

  1. Founded EMS is founded.
  2. Funding First funding round of $15.0M.
  3. Acquisition Acquires Galenika.
  4. Acquisition Acquires Dermacyd.
  5. Acquisition Acquires Lactacyd.
  6. Acquisition Acquires vitamin-se.
  7. Acquisition Acquires Medley.

Web traffic of EMS

The website of EMS (ems.com.br) receives about 102.9K visits a month and ranks #448,926 among all websites worldwide, #416 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    102.9K

    ▲ 12.2% vs previous month

  • Unique visitors
    48.7K

    per month

  • Global rank
    #448,926

    among all websites

  • Category rank
    #416

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with EMS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
quintessencia.com.br
quintessencia.com.br
100%
#1,878,959–
medley.com.br
99%
49.4K#720,608View details
germedpharma.com.br
germedpharma.com.br
99%
#1,428,746–
sindusfarma.org.br
sindusfarma.org.br
98%
#903,687–
emssaude.com.br
emssaude.com.br
94%
#901,640–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 39 similar websites and full traffic analytics for EMS

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 39 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ems

Premium access

Complete news archive for EMS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about EMS

EMS was founded in 1964 and raised its 1st funding round 50 years after it was founded.

EMS is headquartered in Capivari, Brazil. It is registered at Capivari, Sao Paulo, Brazil.

EMS, established in 1964, excels in providing healthcare solutions, traditional pharmaceuticals, generics, and diversified. RD based manufacturer of drugs for multiple therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

EMS has made 5 acquisitions, including Dermacyd, Galenika, and Lactacyd.

EMS has 1 investor. Key investors include Crystal Financial.

EMS operates through Maine Potato Growers, Inc.

The website of EMS receives about 103 thousand visits a month and ranks #448,926 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available